Isabella Orienti

Full Professor at the University of Bologna since 2005, she carries out her research in the field of nano-pharmaceutical formulations for controlled drug delivery and targeting. The research interests are focused in particular to the design and preparation of innovative nanocarriers for ‘natural’ antitumor drugs with the aim to obtain a therapeutic response without toxicity in the long-term treatment of the minimal residual disease. Engaged in national and international research collaborations. Author of numerous publications and Patents. She has been invited to collaborate by prestigious International Centers.